The Value of Enhanced External Counterpulsation on Erectile Dysfunction
EECPED
A Prospective, Randomized Study of Enhanced External Counterpulsation for Patients With Erectile Dysfunction
1 other identifier
interventional
120
1 country
1
Brief Summary
The purpose of this study is to investigate the efficacy of Enhanced External Counterpulsation (EECP) in patients with erectile dysfunction
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2013
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 16, 2013
CompletedFirst Posted
Study publicly available on registry
March 21, 2013
CompletedStudy Start
First participant enrolled
April 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2018
CompletedApril 4, 2017
April 1, 2017
4.9 years
March 16, 2013
April 2, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Erectile function evaluated by International Index of Erectile Function-5 questionnaire
7 weeks
Secondary Outcomes (1)
Endothelial function
7 weeks
Study Arms (2)
Enhanced External Counterpulsation
EXPERIMENTALMen with erectile dysfunction receive Enhanced External Counterpulsation treatment
Control
NO INTERVENTIONMen with erectile dysfunction without Enhanced External Counterpulsation treatment
Interventions
Enhanced external counterpulsation therapy is done by sequential inflation of 3 sets of cuffs wrapped around the lower extremities during diastole and deflation of the cuffs during systole. The systolic deflation/ Diastolic inflation sequence of EECP leads to systolic unloading and diastolic augmentation, resulting in increased blood flow in a pulsatile manner. The patients receive 35-36 hours EECP intervention, 1 -hour session every day over a 7-week period.
Eligibility Criteria
You may qualify if:
- men over 18 years old;
- provide signed informed consent;
- existence of erectile dysfunction
- agree not to use any other erectile dysfunction treatment at least one month;
You may not qualify if:
- history of long drug abuse;
- pelvic, spine, brain trauma or surgery;
- endocrine, liver, lung, kidney disease, malignancies, hematological disorders;
- abnormal urogenital status, such as small testicle (\<2cm), penile plaques;
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
First Affiliated Hospital, Sun Yat-sen University
Guangzhou, Guangdong, 510080, China
Related Publications (1)
El-Sakka A, Morsy A, Fagih B. Enhanced external counterpulsation in patients with coronary artery disease-associated erectile dysfunction. Part I: effects of risk factors. J Sex Med. 2007 May;4(3):771-779. doi: 10.1111/j.1743-6109.2007.00458.x. Epub 2007 Apr 13.
PMID: 17433083BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Yan Zhang, M. D.
First Affiliated Hospital, Sun Yat-Sen University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
March 16, 2013
First Posted
March 21, 2013
Study Start
April 1, 2013
Primary Completion
March 1, 2018
Study Completion
April 1, 2018
Last Updated
April 4, 2017
Record last verified: 2017-04
Data Sharing
- IPD Sharing
- Will not share